Saikadatu, Usba A.
HRN: 17-10-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2025
CEFTRIAXONE 1G (VIAL)
04/08/2025
04/15/2025
IV
2g
Q24h
CAP-MR, T/c PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes